Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
71,153,743
-
Total 13F shares
-
52,033,442
-
Share change
-
+1,124,004
-
Total reported value
-
$423,157,606
-
Put/Call ratio
-
2%
-
Price per share
-
$8.14
-
Number of holders
-
158
-
Value change
-
+$11,668,544
-
Number of buys
-
75
-
Number of sells
-
72
Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q3 2024
As of 30 Sep 2024,
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,033,442 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, First Light Asset Management, LLC, Impax Asset Management Group plc, Daventry Group, LP, PRIMECAP MANAGEMENT CO/CA/, Bank of New York Mellon Corp, Nepsis Inc., WELLINGTON MANAGEMENT GROUP LLP, and MILLENNIUM MANAGEMENT LLC.
This page lists
158
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.